BCPC

Balchem Corp. 10-Q Summary: Period Ended June 30, 1998

Business Context and Reporting Period

This is an unaudited quarterly report (Form 10-Q) for Balchem Corporation, a manufacturer of specialty ingredients, for the period ended June 30, 1998. The company operates in domestic and international markets, focusing on food encapsulation, specialty products, and animal nutrition. As of August 7, 1998, the company had 4,862,756 shares of common stock outstanding. A three-for-two stock split was executed on June 3, 1998, and all per-share data in this report has been retroactively adjusted.

Key Financial Metrics

Liquidity: The company holds $58,000 in cash and cash equivalents. It has a committed credit facility of $2,000,000, with $1,875,000 unutilized as of June 30, 1998.

Material Changes vs. Prior Period

• Revenue: Net sales increased 6% ($810,000) year-over-year for the six-month period, driven by higher volumes in specialty products, international food encapsulation, and animal nutrition. However, the three-month period saw a 1% decline due to customer inventory reductions in the food industry.
• Margins: Gross margin percentage decreased by 3 points. This was attributed to higher costs associated with lower-margin product volumes and additional amortization expense from a customer list purchase.
• Operating Expenses: Total operating expenses decreased by 3% ($103,000) for the six-month period, primarily due to reductions in salary and professional fees, partially offset by higher medical plan costs.
• Debt: Total debt increased significantly to $3,950,000 from $1,500,000 in the prior year. This increase was driven by a $3,000,000 long-term debt borrowing to fund an early payment option on a contingent asset purchase agreement.
• Cash Position: Cash and cash equivalents declined from $736,000 at year-end 1997 to $58,000 at June 30, 1998. This reduction was primarily due to investing activities, including a $3,700,000 payment for intangible assets and $771,000 in capital expenditures.

Outlook, Risks, and Unusual Items

• Unusual Items: On June 25, 1998, the company exercised an early payment option on a 1994 asset purchase agreement, paying $3,700,000 to settle contingent obligations related to a customer list. This eliminated future contingent payments but required significant cash outflow and new debt financing.
• Capital Expenditures: The company is undertaking a plant expansion for its encapsulation product line, with increased capacity expected online in the third quarter. Total capital expenditures for 1998 are projected to be approximately $1,300,000.
• Accounting Standards: The company adopted SFAS No. 131 and SFAS No. 132 effective January 1, 1998. Management is evaluating the impact of SFAS 131 on segment reporting. Other recent standards (SOP 98-1, SOP 98-5, SFAS 133) are not expected to have a material effect on financial position in the near term.
• Risks: The filing notes that results for interim periods are not necessarily indicative of full-year results. Liquidity is supported by operating cash flow and an available credit line, but cash reserves are low relative to recent debt increases.

Investor Verification Checklist

• Verify the sustainability of the 6% revenue growth given the 1% decline in the most recent quarter.
• Confirm the impact of the $3,700,000 contingent payment settlement on future amortization schedules and cash flow.
• Monitor the utilization of the $1,875,000 remaining credit facility given the low cash balance of $58,000.
• Assess the timeline and cost overruns for the plant expansion project scheduled for the third quarter.
• Review the upcoming 10-K for segment reporting disclosures required by SFAS No. 131.